Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
32
datasets available to search
ShareScore release 0.9.0
Dataset results
32 results for “BEV”
The BEV*ARV Project; the Preservation Conditions of Museum Collection Storages in Denmark.
<p>A national survey on the preservation condition in Danish state subsidised museums’ storages was conducted in 2022-23. The collected data has been anonymized and is open for further study and research.</p> <p>The survey consisted of 25 questions (<em>BEV.ARV_Spørgeskema</em>) responded during physical inspections of the storages. 103 museums participated in the survey, 350 buildings and more than 850 storage rooms were physically inspected, and the results recorded. Upon inspection, the preservation/degradation risks addressed in each question were rated according to an A-B-C-D scale. Character A is the best (no degradation risk), D is the lowest (high degradation risk). A guideline (<em>BEV.ARV_Svarvejledning</em>) was used to assist uniform evaluations of the storage conditions.</p> <p>The survey covered museums with art collections, cultural history collections and natural history collections. The indoor climate over one calendar year was recorded in around five hundred of the storage rooms.</p> <p>The collected and uploaded data contain information on the condition of the buildings used for storages, the condition of the storage rooms and the objects stored therein, and how the museums manage and control their collection storage rooms. The survey method has been developed for future inspections and comparative reports of the storage conditions of museum collections.</p> <p>The files included in the datasets have been used in the report to the Ministry of Culture. Furthermore, the data has been applied for making individual museum storage reports with scores and characters for each storage facility. The data is available in Danish only.</p> <p>Content of the folder <strong>Klimadata</strong>:</p> <ul> <li>The file BEV.ARV_2024.04_Dataoversigt provides information regarding type of museum and whether climate data from the storages have been collected or not. </li> <li>The Excel files (<em>M00X-files</em>), one per museum, provides the climate data (Relative Humidity, RH % and Temperature, T °C) from the individual storages, naming corresponding to those applied in the file BEV.ARV_2024.04_Anonymiseret_Raadata.csv</li> </ul> <p>Content of the folder<strong> Rapporter_Supp.Info</strong>:</p> <ul> <li>The file BEV.ARV_2024.04_Anonymiseret_Raadata.csv holds the complete inspection results for all museum storages (the buildings and their rooms).</li> <li>The file BEV.ARV_2024.04_Karaktermodel+Analyse contains analyses carried out and used in the overall report to the Ministry of Culture.</li> <li>For completeness, the report to the Ministry of Culture<em> (BEV.ARV_Slutrapport)</em>, an example of an individual museum storage report ( BEV.ARV_<em>Magasinrapport_Museum_X</em>) the 25 survey questions (<em>BEV.ARV_Spoergeskema</em>) and the response guidelines (<em>BEV.ARV_Svarvejledning</em>), all in Danish, are included. </li> </ul>
Number of BEV (a battery electric vehicle) and PHEV (a plug-in hybrid electric vehicle) vehicles for each Country (2019)
<p>According to the Global E.V. Outlook 2020, China ranks first in vehicles in operation with electric or hybrid engines. In second place in the U.S. and third place in Norway.</p>
Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00280150. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting
ClinicalTrials.gov study NCT06903663. IPD Sharing: UNDECIDED. Countries: 1. Publications: 15.
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
ClinicalTrials.gov study NCT04446416. IPD Sharing: NO. Countries: 1. Publications: 6.
FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT03721653. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
ClinicalTrials.gov study NCT05330429. IPD Sharing: NO. Countries: 10. Publications: 0.
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Gliobla
ClinicalTrials.gov study NCT06496971. IPD Sharing: NO. Countries: 1. Publications: 5.
Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC
ClinicalTrials.gov study NCT02339116. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC
ClinicalTrials.gov study NCT01249638. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Schematic representing the vehicle–to–cell hierarchical overview of a typical electrified powertrain architecture. This represents the system-level context within which the proposed layer optimisation framework has been developed. Two xEV powertrains — a) BEV and b) series PHEV — are chosen as examples to demonstrate how the methodology facilitates common module designs for such battery packs.
<p>Schematic representing the vehicle–to–cell hierarchical overview of a typical electrified powertrain architecture. This represents the<br> system-level context within which the proposed layer optimisation framework has been developed. Two xEV powertrains — a) BEV and b) series PHEV — are chosen as examples to demonstrate how the methodology facilitates common module designs for such battery packs.</p>
A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
ClinicalTrials.gov study NCT02343549. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
ClinicalTrials.gov study NCT00613028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive I
ClinicalTrials.gov study NCT00464646. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03439462. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast
ClinicalTrials.gov study NCT00365417. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05447715. IPD Sharing: NO. Countries: 1. Publications: 0.
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
ClinicalTrials.gov study NCT07198165. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT05739981. IPD Sharing: Not stated. Countries: 1. Publications: 0.
XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC
ClinicalTrials.gov study NCT05970302. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.